Search Results - "Stoner, Karen J"

Once‐Weekly Risedronate in Men With Osteoporosis: Results of a 2‐Year, Placebo‐Controlled, Double‐Blind, Multicenter Study by Boonen, Steven, Orwoll, Eric S, Wenderoth, Dietrich, Stoner, Karen J, Eusebio, Rachelle, Delmas, Pierre D

“…Male osteoporosis is increasingly recognized as a major public health issue. This multinational, 2‐yr, randomized, double‐blind, placebo‐controlled study was…”
Get full text

Short‐Term Recovery Trajectories of Acute Flares in Knee Pain: A UK‐Netherlands Multicenter Prospective Cohort Analysis by Thomas, Martin J., Yu, Dahai, Nicholls, Elaine, Bierma‐Zeinstra, Sita, Conaghan, Philip G., Stoner, Karen J., Neogi, Tuhina, Parry, Emma L., Peat, George

“…Objective To identify distinct recovery trajectories of acute flares of knee pain and associated participant characteristics. Methods Data were from the FLARE…”
Get full text

Evidence for safety and efficacy of risedronate in men with osteoporosis over 4years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study by Boonen, Steven, Lorenc, Roman S., Wenderoth, Dietrich, Stoner, Karen J., Eusebio, Rachelle, Orwoll, Eric S.

“…A 2-year, randomized, double-blind, placebo-controlled study in men with osteoporosis demonstrated that treatment with risedronate 35mg once a week…”
Get full text

Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study by Boonen, Steven, Lorenc, Roman S, Wenderoth, Dietrich, Stoner, Karen J, Eusebio, Rachelle, Orwoll, Eric S

“…Abstract A 2-year, randomized, double-blind, placebo-controlled study in men with osteoporosis demonstrated that treatment with risedronate 35 mg once a week…”
Get full text